Health Management and Social Development Research Center, Faculty of Health, Golestan University of Medical Sciences, Gorgan, Iran.
Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran.
J Prev Med Hyg. 2021 Jul 30;62(2):E298-E304. doi: 10.15167/2421-4248/jpmh2021.62.2.1910. eCollection 2021 Jun.
We aimed to further clarify the epidemiological and clinical characteristics of 2019-nCoV pneumonia and risk factors associated for mortality.
In this study, we included inpatient with acute respiratory distress syndrome at Golestan Hospitals who had been discharged or had died in 2020. Epidemiological, and clinical data were extracted from electronic medical records and compared between recovered and died cases. We used multiple logistic regression methods to explore the risk factors associated with in-hospital death.
Overall 2,835 acute respiratory distress syndrome patients were included in this study, and 874 (30.83%) were positive for 2019-nCoV. Five hundred and sixty-three patients (19.86%) died, 1,687 patients (59.51%) were recovered. Of the total deaths, only 288 (10.15%) were attributed to COVID-19. The most common symptoms at onset of illness were respiratory distress [1,795 (63.32%)], fever [1,601 (56.47%)], dry cough [1,595 (56.26%)], sore throat [445 (15.70%)], and myalgia [342 (12.06%)]. One thousand and twelve (35.7%) had 1 or more coexisting medical conditions. In multiple logistic regression analysis, risk factors associated with the death included older age [OR (Odds Ratio) = 1.03; 95% CI; 1.02-1.04], blood oxygen level (SPO < 93%) (OR = 2.44; 95% CI; 1.79-3.31), comorbidities (OR = 2.15; 95% CI; 1.62-2.84), respiratory distress (OR = 1.74; 95% CI; 1.28-2.37), and headache (OR = 0.44 95% CI; 0.21-0.92).
The 2019-nCoV infection caused collections of severe respiratory illness and was associated to a high ratio of hospitalization in ICU and high mortality. Older age and comorbidities were associated with more risk of death among patients with 2019-nCoV.
本研究旨在进一步阐明 2019 年新型冠状病毒肺炎的流行病学和临床特征,以及与死亡率相关的危险因素。
本研究纳入了 2020 年在戈勒斯坦医院出院或死亡的急性呼吸窘迫综合征住院患者。从电子病历中提取流行病学和临床数据,并比较康复和死亡病例。我们采用多因素 logistic 回归方法探讨与院内死亡相关的危险因素。
本研究共纳入 2835 例急性呼吸窘迫综合征患者,其中 874 例(30.83%)新型冠状病毒检测阳性。563 例(19.86%)患者死亡,1687 例(59.51%)患者康复。在所有死亡病例中,仅有 288 例(10.15%)归因于 COVID-19。发病时最常见的症状是呼吸窘迫[1795 例(63.32%)]、发热[1601 例(56.47%)]、干咳[1595 例(56.26%)]、咽痛[445 例(15.70%)]和肌痛[342 例(12.06%)]。1012 例(35.7%)患者存在 1 种或多种合并症。多因素 logistic 回归分析显示,与死亡相关的危险因素包括年龄较大[比值比(OR)=1.03;95%可信区间;1.02-1.04]、血氧水平(SPO <93%)(OR=2.44;95%可信区间;1.79-3.31)、合并症(OR=2.15;95%可信区间;1.62-2.84)、呼吸窘迫(OR=1.74;95%可信区间;1.28-2.37)和头痛(OR=0.44;95%可信区间;0.21-0.92)。
2019 年新型冠状病毒感染引起了严重的呼吸道疾病,住院患者 ICU 入住率和死亡率均较高。年龄较大和合并症是与 2019 年新型冠状病毒感染患者死亡风险增加相关的危险因素。